Nutrien (NYSE:NTR) Price Target Raised to $62.00 at Scotiabank

Nutrien (NYSE:NTRFree Report) had its price target upped by Scotiabank from $60.00 to $62.00 in a research note issued to investors on Monday,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock.

A number of other equities analysts have also issued reports on the stock. JPMorgan Chase & Co. raised shares of Nutrien from an “underweight” rating to a “neutral” rating and raised their price target for the stock from $40.00 to $50.00 in a research report on Monday, January 13th. TD Securities reduced their price target on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating for the company in a research report on Tuesday, November 12th. Raymond James raised shares of Nutrien from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. CIBC reissued an “outperformer” rating and set a $55.00 price target (down from $60.00) on shares of Nutrien in a research report on Tuesday, December 10th. Finally, Mizuho raised their price target on shares of Nutrien from $52.00 to $55.00 and gave the stock a “neutral” rating in a research report on Thursday, February 20th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $59.50.

View Our Latest Stock Report on Nutrien

Nutrien Stock Down 1.0 %

NTR stock opened at $52.05 on Monday. The firm has a 50 day moving average of $49.51 and a 200 day moving average of $48.29. The stock has a market capitalization of $25.49 billion, a PE ratio of 37.99, a price-to-earnings-growth ratio of 1.19 and a beta of 0.81. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. Nutrien has a 52 week low of $43.69 and a 52 week high of $60.87.

Nutrien (NYSE:NTRGet Free Report) last released its earnings results on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.09). The company had revenue of $5.08 billion during the quarter, compared to analyst estimates of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. Sell-side analysts forecast that Nutrien will post 3.72 earnings per share for the current year.

Nutrien Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be paid a $0.545 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a yield of 4.19%. Nutrien’s dividend payout ratio is currently 159.12%.

Institutional Investors Weigh In On Nutrien

A number of institutional investors have recently added to or reduced their stakes in NTR. Norges Bank acquired a new stake in Nutrien in the 4th quarter valued at $241,958,000. Arrowstreet Capital Limited Partnership boosted its stake in Nutrien by 159.5% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 5,435,627 shares of the company’s stock worth $242,976,000 after purchasing an additional 3,341,169 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Nutrien during the third quarter worth $150,181,000. ARGA Investment Management LP grew its holdings in shares of Nutrien by 25.7% during the fourth quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock worth $270,396,000 after buying an additional 1,236,671 shares in the last quarter. Finally, Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of Nutrien by 78.8% during the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company’s stock worth $121,271,000 after buying an additional 1,100,000 shares in the last quarter. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.